ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.

October 26, 2001

Coalition Of Cooperative Groups Lists High Priority Trials In Breast Cancer.

October 17, 2008

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975